Related Experiment Video
Updated: Aug 4, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Homocysteine and risk of developing hypertension in men
T S Bowman1, J M Gaziano, M J Stampfer
1Veterans Affairs Boston Healthcare System, Massachusetts Veterans Affairs Epidemiology, Research, and Information Center, Boston, MA, USA. tsbowman@partners.org
Insights
Elevated homocysteine levels may increase hypertension risk. This study found higher baseline plasma homocysteine in individuals who developed hypertension, suggesting a potential link between homocysteine and incident hypertension.
Area of Science:
- Cardiovascular Disease Epidemiology
- Metabolic Disorders
- Clinical Biochemistry
Background:
- Cross-sectional studies suggest a link between elevated homocysteine and higher blood pressure.
- The causal role of plasma homocysteine as a risk factor for hypertension is not well-established.
Purpose of the Study:
- To investigate whether plasma homocysteine levels are a risk factor for the development of incident hypertension.
- To determine the association between baseline plasma homocysteine and subsequent hypertension diagnosis.
Main Methods:
- Prospective nested case-control study design.
- Inclusion of 396 participants who developed hypertension and matched controls.
- Measurement of baseline plasma homocysteine levels.
Main Results:
- Participants who developed hypertension had significantly higher baseline plasma homocysteine (12.6 mol/l) compared to controls (11.8 mol/l, P=0.03).
- The highest quintile of homocysteine showed a crude relative risk of 1.56 and a multivariable relative risk of 1.63 for incident hypertension.
- The association between higher homocysteine and hypertension risk was minimally affected by multivariable adjustments, though not statistically significant (P for trend=0.13).
Conclusions:
- Higher baseline plasma homocysteine levels are associated with an increased risk of incident hypertension.
- While the association was not statistically significant, the findings suggest a potential role for homocysteine in hypertension development.
- Further research may be warranted to clarify the clinical significance of homocysteine in hypertension etiology.
Abstract:
In cross-sectional studies, elevated homocysteine levels are associated with higher blood pressure, but it remains unclear whether plasma homocysteine is a risk factor for hypertension. In a prospective nested case-control study, participants who developed hypertension (n=396) had significantly higher levels of baseline plasma homocysteine (12.6 mol/l) than matched controls (11.8 mol/l, P=0.03); compared to those in the lowest quintile, those in the highest quintile had a crude relative risk (RR) of 1.56 (95% confidence interval (CI), 0.98-2.48; P for trend=0.10) and a multivariable RR of 1.63 (95% CI, 0.97-2.74; P for trend=0.13). Higher plasma homocysteine levels at baseline were associated with an increased but non-significant risk of incident hypertension that was minimally affected by multivariable adjustment.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
